| 2025-11-03 |
详情>>
股本变动：
变动后总股本12198.04万股
|
| 2025-11-03 |
详情>>
业绩披露：
2026年一季报每股收益0.65美元,归母净利润8000.00万美元,同比去年增长-19.19%
|
| 2025-11-03 |
财报披露：
美东时间 2025-11-03 盘后发布财报
|
| 2025-10-07 |
股东大会：
将于2025-11-19召开股东大会
会议内容 ▼▲
- 1.To elect six directors to the Board of Directors of The Clorox Company (the “Directors” or the “Board”) for a three-year term expiring at the 2028 Annual Meeting of Shareholders or until their successors are elected and qualified (the “Election Proposal”);
2.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of The Clorox Company (the “Company” or “Cox”) for the year ending June 30, 2026 (the “Ratification Proposal”);
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers as disclosed in the Company’s 2025 Proxy Statement (the “Compensation Proposal”);
|
| 2025-10-03 |
详情>>
内部人交易：
Grier Stacey等共交易24笔
|
| 2025-08-08 |
详情>>
业绩披露：
2023年年报每股收益1.21美元,归母净利润1.49亿美元,同比去年增长-67.75%
|
| 2025-08-08 |
详情>>
业绩披露：
2025年年报每股收益6.56美元,归母净利润8.10亿美元,同比去年增长189.29%
|
| 2025-05-05 |
详情>>
业绩披露：
2025年三季报(累计)每股收益3.87美元,归母净利润4.78亿美元,同比去年增长646.88%
|
| 2025-02-03 |
详情>>
业绩披露：
2025年中报每股收益2.36美元,归母净利润2.92亿美元,同比去年增长153.91%
|
| 2024-10-30 |
详情>>
业绩披露：
2025年一季报每股收益0.80美元,归母净利润9900.00万美元,同比去年增长350.00%
|
| 2024-10-04 |
股东大会：
将于2024-11-20召开股东大会
会议内容 ▼▲
- 1.To elect the 11 director nominees named in the proxy statement;
2.To hold an advisory vote to approve executive compensation;
3.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of The Clorox Company (the Company or Clorox).
|
| 2024-08-08 |
详情>>
业绩披露：
2024年年报每股收益2.26美元,归母净利润2.80亿美元,同比去年增长87.92%
|
| 2024-08-08 |
详情>>
业绩披露：
2022年年报每股收益3.75美元,归母净利润4.62亿美元,同比去年增长-34.93%
|
| 2024-04-30 |
详情>>
业绩披露：
2024年三季报(累计)每股收益0.52美元,归母净利润6400.00万美元,同比去年增长337.04%
|
| 2024-02-01 |
详情>>
业绩披露：
2024年中报每股收益0.93美元,归母净利润1.15亿美元,同比去年增长-37.5%
|
| 2023-11-01 |
详情>>
业绩披露：
2024年一季报每股收益0.17美元,归母净利润2200.00万美元,同比去年增长-74.12%
|
| 2023-10-05 |
股东大会：
将于2023-11-15召开股东大会
会议内容 ▼▲
- 1.To elect the 12 director nominees named in the proxy statement;
2.To hold an advisory vote to approve executive compensation;
3.To hold an advisory vote on the frequency of future advisory votes to approve executive compensation;
4.To ratify the selection of Ernst & Young LLP as the independent registered public accounting firm of The Clorox Company (the Company or Clorox).
|
| 2022-10-05 |
股东大会：
将于2022-11-16召开股东大会
会议内容 ▼▲
- 1.To elect the 12 director nominees named in the proxy statement;
2.To hold an advisory vote to approve executive compensation;
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm.
|
| 2021-10-06 |
股东大会：
将于2021-11-17召开股东大会
会议内容 ▼▲
- 1.To elect the 11 director nominees named in the proxy statement;
2.To hold an advisory vote to approve executive compensation;
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm;
4.To approve the Amended and Restated 2005 Stock Incentive Plan to extend the term of the plan, revise the number of shares available for grant under the plan and make certain other amendments;
5.To consider and vote on the shareholder proposal described in the accompanying proxy statement, if properly presented at the Annual Meeting.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2020-10-06 |
股东大会：
将于2020-11-18召开股东大会
会议内容 ▼▲
- 1.To elect the thirteen director nominees named in the proxy statement;
2.To hold an advisory vote to approve executive compensation;
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm;
4.To approve an amendment to the Company’s Restated Certificate of Incorporation to eliminate the supermajority voting provision.
|
| 2020-02-11 |
除权日：
美东时间 2020-04-21 每股派息1.06美元
|
| 2019-11-19 |
除权日：
美东时间 2020-01-28 每股派息1.06美元
|
| 2019-10-02 |
股东大会：
将于2019-11-20召开股东大会
会议内容 ▼▲
- 1.To elect the eleven director nominees named in the proxy statement;
2.To hold an advisory vote to approve executive compensation;
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm;
4.To approve an amendment to the Company’s Restated Certificate of Incorporation to eliminate the supermajority voting provision.
|
| 2019-09-17 |
除权日：
美东时间 2019-10-29 每股派息1.06美元
|
| 2019-05-20 |
除权日：
美东时间 2019-07-30 每股派息1.06美元
|
| 2019-02-12 |
除权日：
美东时间 2019-04-23 每股派息0.96美元
|
| 2018-11-13 |
除权日：
美东时间 2019-01-22 每股派息0.96美元
|
| 2018-10-01 |
股东大会：
将于2018-11-14召开股东大会
会议内容 ▼▲
- 1.To elect the twelve director nominees named in the proxy statement;
2.To hold an advisory vote to approve executive compensation;
3.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm;
4.To approve an amendment to the Company’s Restated Certificate of Incorporation to eliminate the supermajority voting provision.
|
| 2018-09-18 |
除权日：
美东时间 2018-10-30 每股派息0.96美元
|
| 2018-05-21 |
除权日：
美东时间 2018-07-31 每股派息0.96美元
|
| 2018-02-13 |
除权日：
美东时间 2018-04-24 每股派息0.96美元
|
| 2017-11-14 |
除权日：
美东时间 2018-01-23 每股派息0.84美元
|
| 2017-09-22 |
股东大会：
将于2017-11-15召开股东大会
会议内容 ▼▲
- 1.To elect the twelve director nominees named in the proxy statement;
2.To hold an advisory vote to approve executive compensation;
3.To hold an advisory vote on the frequency of future advisory votes to approve executive compensation;
4.To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm;
5.To approve the material terms of the performance goals under the Company’s 2005 Stock Incentive Plan;
6.To approve the Company’s equity award policy for non-employee directors;
7.To consider and act upon one stockholder proposal, if properly presented at the Annual Meeting.
|
| 2017-09-13 |
除权日：
美东时间 2017-10-24 每股派息0.84美元
|
| 2017-05-09 |
除权日：
美东时间 2017-07-17 每股派息0.84美元
|
| 2017-02-07 |
除权日：
美东时间 2017-04-17 每股派息0.80美元
|
| 2016-11-15 |
除权日：
美东时间 2017-01-23 每股派息0.80美元
|
| 2016-09-23 |
股东大会：
将于2016-11-16召开股东大会
会议内容 ▼▲
- 1. To elect the eleven director nominees named in the proxy statement;
2. To conduct an advisory vote to approve the compensation of the Company’s named executive officers;
3. To ratify the selection of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending June 30, 2017;
4. To consider and act upon one stockholder proposal, if properly presented at the Annual Meeting.
|
| 2016-09-13 |
除权日：
美东时间 2016-10-24 每股派息0.80美元
|
| 2016-05-16 |
除权日：
美东时间 2016-07-25 每股派息0.80美元
|
| 2016-02-09 |
除权日：
美东时间 2016-04-18 每股派息0.77美元
|
| 2015-11-17 |
除权日：
美东时间 2016-01-25 每股派息0.77美元
|
| 2015-09-15 |
除权日：
美东时间 2015-10-26 每股派息0.77美元
|
| 2015-05-11 |
除权日：
美东时间 2015-07-20 每股派息0.77美元
|
| 2015-02-10 |
除权日：
美东时间 2015-04-20 每股派息0.74美元
|
| 2014-11-18 |
除权日：
美东时间 2015-01-26 每股派息0.74美元
|
| 2014-09-16 |
除权日：
美东时间 2014-10-27 每股派息0.74美元
|
| 2014-05-12 |
除权日：
美东时间 2014-07-21 每股派息0.74美元
|
| 2014-02-11 |
除权日：
美东时间 2014-04-21 每股派息0.71美元
|
| 2013-11-19 |
除权日：
美东时间 2014-01-27 每股派息0.71美元
|
| 2013-09-17 |
除权日：
美东时间 2013-10-28 每股派息0.71美元
|
| 2013-05-13 |
除权日：
美东时间 2013-07-22 每股派息0.71美元
|
| 2013-02-13 |
除权日：
美东时间 2013-04-22 每股派息0.64美元
|
| 2012-11-13 |
除权日：
美东时间 2013-01-18 每股派息0.64美元
|
| 2012-09-12 |
除权日：
美东时间 2012-10-22 每股派息0.64美元
|
| 2012-05-14 |
除权日：
美东时间 2012-07-23 每股派息0.64美元
|
| 2012-02-14 |
除权日：
美东时间 2012-04-23 每股派息0.60美元
|
| 2011-11-15 |
除权日：
美东时间 2012-01-24 每股派息0.60美元
|
| 2011-09-13 |
除权日：
美东时间 2011-10-24 每股派息0.60美元
|
| 2011-05-18 |
除权日：
美东时间 2011-07-25 每股派息0.60美元
|
| 2011-02-15 |
除权日：
美东时间 2011-04-25 每股派息0.55美元
|
| 2010-11-16 |
除权日：
美东时间 2011-01-25 每股派息0.55美元
|
| 2010-09-14 |
除权日：
美东时间 2010-10-25 每股派息0.55美元
|
| 2010-05-19 |
除权日：
美东时间 2010-07-26 每股派息0.55美元
|